Association between Prevalent Flagellated Bacteria in Gut Microbiota and Cardiovascular Benefits in Humans
Jensen H. C. YiuiD, Jieling Cai, Samson W. M. Cheung, Karie Tsz-Ching Chin, Chi Fai Chan, E. C., Rakesh SharmaiD, Bernhard DorweileriD, Connie W. WooiD
Abstract
BackgroundIncreasing evidence has shown associations between gut microbiota and cardiovascular risks. However, whether sex influences the cardiovascular outcome of gut microbiota remains elusive. MethodsThe gut microbiota metagenomic data from two previous population-based cohorts and the proteomics data from human liver samples were analyzed. ResultsThrough a sex-based analysis of 500 Functional Genomics Project (500FG) cohort, we found that the capacity of producing flagellin in Eubacterium rectale, Roseburia Intestinalis and Roseburia inulinivorans partially explained the levels of high-density lipoprotein-cholesterol (HDL-C) and apolipoprotein A1 in female participants. By comparing the bacterial species showing positive correlations with HDL-C and the flagellin species found in human liver samples, we found that E. rectale and R. inulinivorans appeared to be the major prevalent flagellated species in gut microbiota contributed to the hosts HDL-C level. The analysis of the Chinese-based cohort in which the male participants had relatively higher abundance of these two bacteria, the abovementioned positive correlation was also observed. ConclusionsThe flagellin-producing function of E. rectale and R. inulinivorans in the gut microbiota partially explained the HDL-C level in the host, and there is a sex-specific difference in the sensitivity of this beneficial interaction. Our findings suggest a potential interaction between commensal bacteria and the host that yields a cardiovascular benefit. Clinical PerspectiveO_ST_ABSWhat is new?C_ST_ABSO_LIThe flagellin-producing capacity of certain species in gut microbiota is positively associated with the HDL-C and ApoA1 levels in human. C_LIO_LIBy comparing the flagellated bacteria in the gut and flagellin species in the liver, Eubacterium rectale and Roseburia inulinivorans are shown to be the most prevalent species contributing to such cardiovascular benefits. C_LIO_LIThe sensitivity of such beneficial interaction with the gut flagellated bacteria is different between male and female. C_LI What are the clinical implications? (maximum 100 words, formatted as 2-3 bullets)O_LIBeside the role in metabolic inflammation, gut microbiota can be beneficial against cardiovascular risk by modulating HDL-C level through certain flagellated species. C_LIO_LIThe interaction between flagellated bacteria in the gut and the host provide a different insight in exploring potential therapeutic targets to increase HDL-C level. C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The gut microbiome across the cardiovascular risk spectrum
Femke M. Prins, Valerie Collij, … Ranko Gaćeša·European Journal of Preventive CardiologyPeer-reviewed·Dec 7, 2023
- Probiotic strains improve high-fat diet-induced hypercholesterolemia through modulating gut microbiota in ways different from atorvastatin
- The impact of plasma membrane lipid composition on flagella-mediated adhesion of enterohemorrhagic Escherichia coli
H. Cazzola, L. Lemaire, … Y. Rossez·mSpherePeer-reviewed·Oct 28, 2020
- Sex-specific effects of gut microbiome on shaping bile acid metabolism
Yifei Yang, Liang Chi, … Kun Lü·bioRxiv·Jun 27, 2024
- Gut Microbiota Changes in Nonalcoholic Fatty Liver Disease and Concomitant Cardiovascular Diseases
O. H. Kurinna·bioRxiv·Jul 27, 2020
- Associations Between Gut Microbiome and 24-Hour Blood Pressure Variability: A Cross-sectional Study Highlighting Sex Differences and Potential Therapeutic Targets
Preeti Dinesh Virwani, Gordon Qian, … Kui Kai Lau·Gut MicrobiomePeer-reviewed·Jan 1, 2026